Modelling nasal high flow therapy effects on upper airway resistance and resistive work of breathing by Adams, Cletus F. et al.
Modelling Nasal High Flow Therapy Effects on Upper1
Airway Resistance and Resistive Work of Breathing2
Cletus F. Adams1, Patrick H. Geoghegan 2, Callum J. Spence 3, Mark C. Jermy 1 ,3
affiliations: 1 Department of Mechanical Engineering, University of Canterbury, Christchurch 8041, New 
Zealand; 2 School of Life and Health Sciences, Aston University, Birmingham, B4 7ET, England, United 
Kingdom 3 Fisher and Paykel Healthcare Limited, 15 Maurice Paykel Place, 6 Auckland 2013, New Zealand
correspondence: Mark Jermy, Department of Mechanical Engineering, University of Can-
terbury, Christchurch 8041, New Zealand; e-mail: mark.jermy@canterbury.ac.nz8
1
4
5
6
7
Abstract9
Aim: The goal of this paper is to quantify upper airway resistance with and without10
nasal high flow (NHF) therapy. For adults, NHF therapy feeds 30 to 60 L/min of warm11
humidified air into the nose through short cannulas which do not seal the nostril. NHF12
therapy has been reported to increase airway pressure, increase tidal volume (Vt) and13
decrease respiratory rate (RR), but it is unclear how these findings affect the work14
done to overcome airway resistance to air flow during expiration. Also, there is little15
information on how the choice of nasal cannula size may affect work of breathing. In this16
paper, estimates of airway resistance without and with different NHF flow (applied via17
different cannula sizes) were made. The breathing efforts required to overcome airway18
resistance under these conditions were quantified.19
Method : NHF was applied via three different cannula sizes to a 3-D printed human20
upper airway. Pressure drop and flow rate were measured and used to estimate inspi-21
ratory and expiratory upper airway resistances. The resistance information was used22
to compute the muscular work required to overcome the resistance of the upper airway23
to flow.24
Results: NHF raises expiratory resistance relative to spontaneous breathing if the25
breathing pattern does not change but reduces work of breathing if peak expiratory26
flow falls. Of the cannula sizes used, the large cannula produced the greatest resistance27
and the small cannula produced the least. The work required to cause tracheal flow28
through the upper airway was reduced if the RR and minute volume are reduced by29
NHF. NHF has been observed to do so in COPD patients (Braunlich et al, 2013). A30
reduction in I:E ratio due to therapy was found to reduce work of breathing if the peak31
inspiratory flow is less than the flow below which no inspiratory effort is required to32
overcome upper airway resistance.33
Conclusion: NHF raises expiratory resistance but it can reduce the work required34
to overcome upper airway resistance via a fall in inspiratory work of breathing, RR35
and minute volume.36
keywords: nasal high flow therapy; work of breathing; zero pressure inspiratory flow37
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1 Introduction38
NHF involves the administration of warmed and humidified air, which may be enriched39
with oxygen, at flow rates up to 60 L/min for adults and 8 L/min for neonates.1 2 3 4 The40
conditioned air is supplied to the patient via a nasal cannula having soft nasal prongs which41
do not seal the nostril. The NHF flow is often greater than the peak inspiratory demand.42
Surplus air is expelled through the gap between prong and nares, and through the mouth43
if open. NHF is applied to critically ill patients suffering from conditions such as chronic44
airway disorders, mild obstructive sleep apnoea, acute hypoxemic respiratory failure and45
post operative hypoxemia.5 6 7 846
In the last decade, the paucity of information on the mechanisms of action of NHF47
therapy prompted Dysart et al.9 to postulate mechanisms of action of NHF. These include48
a reduction in mechanical work of breathing (WOB) - the muscular effort which drives49
breathing. Dysart et al.9 suggested that inspiratory WOB was reduced as NHF provides50
air flow, which supplies inspiratory flow without effort by the patient. A popular surrogate51
for effort of breathing is the pressure rate product (PRP) which is usually calculated as52
the product of the breathing frequency and esophageal pressure change (between end of53
expiration and end of inspiration). Rubin et al.10 , Willis et al.11 and Pham et al.12 used the54
PRP to quantify WOB under conditions of NHF in a population of neonates and children and55
reported a decrease in WOB. Using the electrical impedance tomography technique, Pham56
et al.12 observed a reduction in the diaphragmatic electrical activity of 24 infants (age = 157
- 12 months) during NHF - suggesting, in some sense, the oﬄoading of the diaphragmatic58
muscular effort and hence a reduction in mechanical work of breathing.59
Whilst these studies provide insights into the benefits derived from NHF from the energy60
cost standpoint, PRP is a surrogate rather than the true work of breathing and these studies61
considered only the inspiratory aspect of breathing. Saslow et al.13 used the gold standard62
method of computing WOB i.e. finding the area under the pressure-volume curve and found63
that the neonatal WOB associated with NHF of 3 - 5 L/min and CPAP of 6 cmH2O are64
comparable. The WOB prior to the administration of NHF and the effect of cannula size65
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were not studied.66
The questions we seek to answer are in three parts. Firstly, when NHF is applied,67
how much change occurs in the upper airway resistance in the inspiration and expiration68
directions? Secondly, how much breathing effort is required to overcome these resistances;69
and thirdly how does cannula size affect these quantities? An anatomically representative70
rigid model of the upper airway, from the trachea to the nares was used - according to Ferris71
et al.,14 this section typically constitutes about two-thirds of the total airway resistance.72
Using a refined model based on the work of Otis et al.,15 the effort to overcome upper airway73
resistance to air flow is calculated for a range of NHF and cannula sizes. As the interest74
lies in how NHF affects upper airway resistance, the lower airway (below the trachea) is not75
included in the experimental setup. The resistance of the lower airway has been reported76
to be linear (independent of flow) up to 120 L/min.14 As the peak inspiratory flow during77
spontaneous breathing in young male adults is < 60 L/min,16 17 18 it is reasonable to assume78
that for the same minute volume, there will be no change in resistance of the lower airway79
during NHF. If NHF changes the minute volume, the change in work done in the lower80
airways will have the same trend as the work done in the upper airway.81
2 Materials and Methods82
2.1 Upper Airway Model (UAM)83
Computed tomography (CT) images of the upper airway of a 44 year old male adult, with84
no apparent airway abnormality, and in a mouth open resting state, were segmented to85
extract the airway. The sinuses were deleted and terminated at the trachea. A 3D model86
was 3D printed in acrylic (Visijet EX200) - Fig. 1. To study mouth closed breathing, which87
is recommended for NHF, the oral opening was sealed. Tests on models made from scans of88
subjects with their mouth closed, and subjects scanned with their mouth open, but with the89
oral cavity of the model sealed closed, showed these to have a similar resistance to flow. A90
complete description of model making methods can be found in the report by Geoghegan et91
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al.19 A hole of diameter 1 mm was drilled directly into the trachea for pressure measurement.92
A positive displacement programmable piston pump (PP) (Van Hove et al.20) was connected93
to the UAM (Fig. 1). The PP is able to produce bidirectional flows up to 60 L/min. A TSI94
4000 flow meter (industry calibrated) was used to confirm the flow delivered by the PP was95
as expected from the piston velocity. A difference of 6.4 % was found thus all piston flows96
were multiplied by a factor of 1.064. An AIRVOTM2 nasal high flow device (manufactured by97
Fisher & Paykel Healthcare Limited, Auckland, New Zealand) was used to administer NHF98
via a breathing circuit and nasal cannula (Fisher & Paykel Healthcare Ltd, Optiflow). A99
pressure transducer (AMS 5915, Analog Microelectronics GmbH, Germany) was connected100
to the pressure tap in the trachea (P1 in Fig. 1). P2 is the atmospheric pressure.101
Figure 1: The experimental setup shows the upper airway model connected to the PP and the AIRVOTM2.
Tracheal pressure is sampled from point P1. P2 is the atmospheric pressure
2.2 Experimental procedure102
The resistance of the UAM itself was first determined by pushing steady flow rates (F )103
ranging from -50 L/min to 50 L/min through the UAM. Negative flow rates denote inspira-104
tion. Rohrer’s equation,15 Eq.1, describes the relationship between air flow and the driving105
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pressure (Pru)106
Pru = K1F + K2F
2 (1)
where K1 and K2 are resistance coefficients. K1 and K2 in Eq.1 are determined by least-107
squares fitting to the recorded flow (F ) and differential pressure data (Pru = P2 − P1).108
Airway resistance, R, is defined as R = Pru/F (Eq.2)109
R = K1 + K2F (2)
Due to the second term in Eq.2, airway resistance depends on flow rate. Tracheal pressure110
was recorded with no NHF applied to the UAM. NHF was then applied via each of the three111
nasal cannulas: the small (OPT842), medium (OPT844) and large (OPT846) cannula (Fisher112
& Paykel Healthcare). For each cannula, the flow rate through the cannula (NHF flow rate)113
was set at 20 L/min (NHF20), 40 L/min (NHF40) and 60 L/min (NHF60) in turn. The PP114
was used to deliver rectangular flow waves in which the steady flow ranged from -50 to 50115
L/min in steps of 10 L/min. At these pressures, the air density is virtually constant and the116
piston motion determines the tracheal flow.117
3 Results118
3.1 Upper airway pressure-flow characteristics119
Fig. 2 shows the pressure-flow data obtained via the medium cannula for both breathing120
directions, inspiration and expiration during NHF20, NHF40 and NHF60. That of the zero-121
therapy state, ZT, (no cannula in place, no NHF flow) is also shown. The pressure rises122
quadratically with flow rate i.e. the K2 term in Eq.1 cannot be neglected. Note that on123
Fig. 2, at zero tracheal flow (piston not moving), the inflow through the cannula is balanced124
by outflow through the leak area between the nares and cannula prongs. The pressure (P2)125
at zero net flow is non-zero for all NHF and increases with increasing NHF. These pressures126
are produced by the stagnation of the cannula jet in the upper airway.127
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Figure 2: Pressure-flow relationship for adult UAM during inspiration and expiration at ZT and NHF20,
NHF40 and NHF60, administered via the medium cannula. The error bars represent two standard deviations
in pressure measurement.
It is observed that at NHF60, as tracheal flow increases (in both directions) expiration128
requires more pressure compared to inspiration whilst at ZT, inspiratory tracheal pressure129
eventually becomes greater than expiratory tracheal pressure as tracheal flow increases. From130
ZT towards NHF60, the changeover from a greater inspiratory effort to a greater expiratory131
effort occurs after NHF20. Nonetheless, at NHF60, the pressure difference required to pro-132
duce a difference in tracheal flow is greater during inspiration. As shown in Fig. 2, the change133
in inspiratory pressure (dPi) required to increase tracheal flow by 10 L/min is greater than134
the pressure (dPe) required during expiration to increase tracheal flow by the same amount.135
This suggests a greater inspiratory resistance.136
At the flow rate named zero pressure inspiration flow (ZPIF) in Fig. 2, the pressure at the137
trachea required to drive inspiratory flow is zero. As NHF increases the ZPIF also rises. At138
flow rates between ZPIF and zero, no muscular effort is required to drive inspiration against139
upper airway resistance. In this state, inspiration is driven by NHF.140
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In Fig. 3, the breathing flow of a male adult (age = 24 years) is shown. Tobin et al.21141
measured the breathing pattern of 65 normal subjects from 20 to 81 years of age and found no142
effect of age on the mean values of various breathing pattern components nor any significant143
correlation with body height. Negative flows represent tracheal flows in the inspiratory144
direction. Fig. 3 is the tracheal flow used in ZT and NHF > 0 cases studied here with NHF-145
induced modulations in amplitude and period defined for each case. The horizontal lines
Figure 3: A breathing flow pattern of a male adult (age = 24). The ZPIF for NHF20, NHF40 and NHF60
found for the UAM are shown.
146
represent the ZPIF. When NHF20 is applied, for instance, from the start of inspiration up147
to a flow rate of -7.5 L/min (ZPIF), no respiratory effort will be required to overcome upper148
airway resistance but that needed to overcome lower airway resistance and lung elastance.149
Muscular effort is only required to overcome upper airway resistance between time = a and150
time = b until expiration begins. As NHF flow rate increases, ZPIF rises and less effort151
is required over the inspiratory phase. Note that the ZPIF can be greater than the peak152
inspiratory flow suggesting effortless inspiratory breathing across the upper airway.153
Table 1 shows the K1 and K2 values fitted to inspiration and expiration during ZT,154
NHF20, NHF40 and NHF60. These values are used in all subsequent calculations.155
8
Table 1: The K1 and K2 values of the UAM for inspiration and expiration during ZT, NHF20, NHF40 and
NHF60. The R2 values denote the coefficient of determination of the least squares fit of the pressure-flow
plots to Rohrer’s equation (Eq.1).
Inspiration Expiration
K1
(cmH2O/L/s)
K2
(cmH2O/L
2/s2)
R2
K1
(cmH2O/L/s)
K2
(cmH2O/L
2/s2)
R2
ZT 0.04 4.32 0.99 0.20 3.61 0.99
NHF20 0.45 4.32 1.00 0.57 3.62 0.99
NHF40 1.32 3.88 0.99 1.18 3.47 0.99
NHF60 2.14 3.65 1.00 1.07 4.09 1.00
3.2 Effect of cannula size on resistance156
Fig. 4a shows the expiratory pressure-flow plots at ZT, NHF20, NHF40 and NHF60 for all157
cannula and the flow rates induced by the piston motion (tracheal flow). The error bars158
represent two standard deviations in pressure calculated over 5 cycles. Except for NHF20,159
the pressure produced by the medium cannula is almost the same as that of the large cannula.160
NHF rates have a greater effect on pressure than cannula size does. The differences in161
pressure between small and large cannula increases with tracheal flow. The K1 and K2162
deduced from each of the curves shown in Fig. 4a were used to compute the resistance at a163
tracheal flow of 30 L/min (Fig. 4b).164
Though the large cannula tends to produce the greatest resistance at all NHF values,165
the error bars of the large and medium cannula overlap. Replacing the large cannula with166
the small cannula reduces expiratory resistance by 13 %, 20 % and 22%, respectively corre-167
sponding to NHF20, NHF40 and NHF60.168
3.3 Resistive work of breathing169
Having estimated the upper airway resistances (for inspiration and expiration) under NHF170
conditions, the metabolic energy cost required for tracheal flow under NHF conditions is171
now estimated. Eq.3 defines the breathing flow waveform, F . The work done per breath172
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(a) Expiratory pressure-flow plot (all cannula sizes) (b) Upper airway resistance at 30 L/min
Figure 4: (a) The expiratory pressure-flow relationship for the UAM at ZT, NHF20, NHF40 and NHF60
administered via the small, medium and large cannula. The error bars represent two standard deviations
in pressure measured over 5 cycles (b) A plot of the resistance of the UAM at a tracheal flow of 30 L/min
when NHF20, NHF40 and NHF60 were administered via the small, medium and large cannula sizes. The
standard errors in resistance due to errors in flow and pressure are shown by the error bars
comprises of the pressure used to overcome the resistance of the lung to inflation (elastance)173
- designated here as Pe - plus the pressure that overcomes upper airway resistance (Pru) and174
lower airway resistance (Prl). Eq.4 defines the mechanical work done per breath (WOB), as175
first used by Otis et al.15176
F =
dV
dt
(3)
177
WOB =
∫
(Pru + Prl + Pe)dV =
∫
(Pru + Prl + Pe)Fdt (4)
Per the scope of the present experimental work, only the Pru term of Eq. 4 is used and by178
substituting Eq. 1 into Eq. 4, Eq. 5 describes the total mechanical work done (rWOB) on179
inspiratory and expiratory tracheal flow via the upper airway in one minute.180
rWOB = RR({
∫ b
a
(K1F
2 + K2F
3)dt}inspiration + {
∫ Te
0
(K1F
2 + K2F
3)dt}expiration) (5)
where a and b are the times corresponding to the two intercepts of the ZPIF with the181
flow waveform (Fig. 3) and Te is the expiratory time. Respiratory rate (RR) is in breaths182
10
per minute (bpm). rWOB is also the average power of working against the upper airway183
resistance, expressed in J/min.184
Nasal high flow therapy (NHF) has been widely reported to reduce RR22 23 but its effect185
on tidal volume (Vt) and minute volume (MV ) is complicated by disease state,
23 and wake-186
fulness.24 The effect of NHF on I:E ratio has been investigated by Fraser et al.25 The results187
were used to infer how variation in I:E ratio might affect rWOB. In what follows, rWOB is188
investigated in three categories of subjects administered with NHF namely: (1) subjects in189
whom RR and Vt do not change with NHF (2) subjects with NHF-dependent RR and Vt but190
I:E ratio remains constant (3) subjects with NHF-dependent RR, Vt and I:E ratio.191
3.3.1 Subject in whom RR and Vt do not change192
Here, rWOB was calculated using the typical young adult resting state RR of 15 bpm and193
Vt of 0.5 L.
26 27 The mean I:E ratio for 47 young adults without NHF (age = 28.6 ± 5.3)194
found by Tobin et al.21 to be 0.74 was used in the calculation of rWOB. The change in195
rWOB due to NHF (rWOBNHF ), is calculated as a percentage of the ZT rWOB (rWOBZT )196
i.e. %∆ = 100(rWOBNHF − rWOBZT )/rWOBZT . The results are presented in Table 2.197
The net effect is that rWOB rises with NHF up to NHF40 but at NHF60 rWOB falls. The198
rWOB at NHF60 falls below that at NHF40 because at NHF60, the ZPIF produces a greater199
reduction in inspiratory effort done it does at NHF40.200
3.3.2 Subject with NHF-dependent RR and Vt201
The observed respiratory response to NHF where there is a fall in RR,22 28 29 a rise in Vt
28 22
202
but a general fall in MV 23 was considered. Brau¨nlich et al.23 reported that 20 L/min NHF203
reduced MV by approximately 1 L in 15 patients suffering from COPD (mean age = 67.7204
years). Corley et al.22 studied 20 COPD patients (mean age = 65 years), who were prescribed205
50 L/min NHF, and observed a 3.4 bpm reduction in RR. Based on these observations, MV206
was reduced by 1 L for every 20 L/min of NHF and RR was reduced by 3.4 bpm for every207
50 L/min NHF. The I:E ratio was 0.74.21208
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Table 2: The rWOB at ZT, NHF20, NHF40 and NHF60 for inspiration (rWOBi) and expiration (rWOBe).
rWOB represents the sum of inspiratory and expiratory rWOB and %∆ is the percentage change in rWOB
relative to ZT. rWOBi* is the rWOBi if the ZPIF effect is ignored
Inspiration Expiration Total
rWOBi*
(J/min)
rWOBi
(J/min)
rWOBe
(J/min)
rWOB
(J/min)
%∆
ZT 0.54 0.54 0.22 0.76 -
NHF20 0.67 0.66 0.28 0.94 24
NHF40 0.89 0.81 0.38 1.19 57
NHF60 1.12 0.45 0.39 0.84 11
In Table 3 the inspiratory, expiratory and total rWOB are shown. The percentage change209
in rWOB relative to ZT (as was done in the previous case) is also shown with the negative210
sign indicative of a reduction. It is noticeable that rWOB during NHF falls below rWOB at
Table 3: Inspiratory WOB (rWOBi), expiratory WOB (rWOBe), total WOB (rWOB) and percentage
change (%∆) in rWOB relative to the ZT rWOB (shown in Table 2) when RR and MV falls but I:E ratio
remains unchanged. rWOBi* is the rWOBi if the ZPIF effect is ignored.
rWOBi*
(J/min)
rWOBi
(J/min)
rWOBe
(J/min)
rWOB
(J/min)
%∆
NHF20 0.45 0.45 0.19 0.64 -16
NHF40 0.41 0.27 0.18 0.44 -42
NHF60 0.34 0.13 0.11 0.24 -68
211
ZT for all considered NHF. It is concluded that at least for the upper airway, irrespective of212
breathing direction (inspiration or expiration), NHF increases rWOB (work done on tracheal213
flow in a minute) when MV remains unchanged but it produces a significant fall in rWOB214
when MV falls.215
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3.3.3 Subject with NHF-dependent RR, Vt I:E ratio216
Fraser et al.25 found that administering NHF of 30 L/min caused a reduction in I:E ratio217
of about 13 % in 30 males. To the authors knowledge, this is the only report of I:E ratio218
variation with NHF to date and was used to scale the I:E ratio with NHF (13 % fall in I:E219
ratio for every 30 L/min NHF). The relationship between NHF, MV, Vt and RR was the220
same as in Section 3.3.2. The results are shown in Table 4.221
Table 4: Inspiratory rWOB (rWOBi), expiratory rWOB (rWOBe), total rWOB (rWOB) and percentage
change (%∆) in rWOB relative to the ZT rWOB (shown in Table 2) when RR and MV falls and NHF
changes I:E ratio. rWOBi* is the rWOBi if the ZPIF effect is ignored.
rWOBi*
(J/min)
rWOBi
(J/min)
rWOBe
(J/min)
rWOB
(J/min)
%∆
NHF20 0.52 0.52 0.17 0.69 -9
NHF40 0.54 0.43 0.15 0.58 -24
NHF60 0.52 0.27 0.08 0.35 -54
It is observable that relative to the previous case the rWOB (for NHF dependent I:E222
ratio) increases for NHF20, NHF40 and NHF60. This happens because reducing I:E ratio223
means reducing inspiratory time but increasing expiratory time. This leads to a fall in peak224
expiratory flow, a rise in peak inspiratory flow and the widening of the difference between225
the ZPIF and the peak inspiratory flow. If after a fall in I:E ratio the ZPIF remains greater226
than peak inspiratory flow, rWOB will be further reduced because expiratory effort will fall227
and inspiration will be effortless.228
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4 Discussion229
4.1 Effect of NHF on airway pressure during expiration230
Mundel et al.24 found that NHF of 15 L/min produced a greater nasal pressure with the231
large cannula compared to the small cannula.24 Their model was simpler than the current232
one, with an axis-symmetric passage including a constriction that simulated the nasal valve.233
Their results and the present results agree qualitatively.234
The present work is the first measurement of the resistance due to the cannula in an235
anatomically realistic geometry. As expected, the large cannula was found to produce a236
greater resistance than the small cannula. At NHF40 and tracheal flow of 30 L/min for237
instance, the expiratory resistance due to NHF administration via the large cannula was 20238
% higher than when delivered through the small cannula. The leak area between the cannula239
prong and the nostril contributes to the rise in pressure with cannula size as the expired flow240
must pass through a smaller area with greater pressure loss.241
Several researchers30 31 32 33 have reported on the increase of airway pressure with increas-242
ing NHF as found in the present study. The present results suggest that whilst it may be243
possible to increase the extrinsic positive end-expiratory pressure (ePEEP) to reduce atelac-244
tasis by increasing cannula size, such a decision should be weighed against the possible rise245
in the expiratory effort of breathing.246
4.2 Effect of NHF on resistive work of breathing247
Dysart et al.9 postulated that matching NHF with inspiratory flow demand may attenuate248
nasopharyngeal resistance and lead to reduction of work of breathing. Further, the nasal249
cannula is designed to reach past the nasal valve (which has significant resistance) leading250
to a reduction of inspiratory work of breathing. The fall in inspiratory work of breathing251
due to NHF can be explained in terms of the NHF-induced rise of the ZPIF, below which252
inspiration through the upper airway requires no respiratory effort.253
Information on expiratory effort against a cannula jet is scarce in the literature.9 The254
14
present study indicates a rise in expiratory resistance to flow when NHF is applied. The255
expiratory flow must negate the momentum of the jet, leading to a rise in static pressure256
towards stagnation pressure. It follows that the greater the NHF, the greater the jet stag-257
nation pressure and the effort that will be required to overcome and reverse the jet flow. If258
NHF raises the total volume of air to be expelled, a rise in flow rate through the leak area259
and a consequent rise in expiratory pressure is expected.260
In spite of the longer expiratory time (I:E ratio < 1), rWOBe was lower than rWOBi be-261
cause the peak expiratory flow was lower than the peak inspiratory flow. Also the resistance262
coefficients for inspiration were found to be greater. When RR and Vt remain unchanged,263
NHF dependent increase in rWOB (work required for tracheal flow through the upper airway264
per minute or power of breathing in J/min) was observed (Table 2) due to the increased in-265
spiratory and expiratory resistance. At a constant I:E ratio, the fall in RR and consequently266
MV produced a reduction in rWOB in an NHF dependent manner (Table 3) partly due to267
the rise in ZPIF with NHF and a fall in peak expiratory flow with NHF. rWOB will further268
reduce if the ZPIF remains above the peak inspiratory flow after a fall in I:E ratio.269
It has been reported that chronic obstructive pulmonary disease (COPD) and airway270
restrictive diseases are characterised by a rise in RR.34 21 Since COPD augments expiratory271
resistance, which in turn demands a greater breathing effort, the fall in RR23 35 36 coupled272
with the possible decrease in work of breathing upon the application of NHF may provide a273
significant relief to the respiratory musculature of COPD patients.274
Though RR has been widely reported to fall with NHF,22 23 29 varied findings exists as275
to how NHF impacts Vt and MV . Brau¨nlich et al.
23 observed a general decrease in MV276
due to a decrease in RR for healthy subjects, idiopathic pulmonary fibrosis (IPF) patients277
and chronic obstructive pulmonary disease patients (COPD) upon the administration of 20278
L/min NHF, however, Vt decreased amongst the healthy subjects, increased amongst the279
COPD patients and remained unchanged in the IPF patients. In a study performed on 10280
healthy adults by Mundel et al.,24 it was found that application of NHF did not change MV281
during wakefulness (as RR was offset by a rise in Vt), however it decreased MV during sleep282
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(by decreasing Vt, no change in RR was observed). Using electrical impedance tomography,283
Diab et al.35, Riera et al.28 and Corley et al.22 reported a rise in Vt in response to NHF.284
Diab et al.35 however measured MV as well, finding no change in it.285
Wakefulness and disease state complicate the influence of NHF on Vt and MV. Given286
the convincing body of evidence supporting a fall in RR, if MV rises due to NHF, a rise287
in Vt traceable to an increase in inspiratory flow is suggested. Under such circumstances,288
work of breathing may be higher with NHF than without. Also, work of breathing may be289
expected to fall below that at ZT if MV falls due to a fall in both RR and Vt. Nonetheless,290
the interpretation of the therapeutic benefit of NHF to a patient must be comprehensive291
and not restricted to work of breathing alone as other parameters such as dyspnea, mouth292
dryness,7 functional residual capacity,35 22 end-tidal and blood arterial CO2 concentration
37
293
also indicate the well being of patients in response to NHF.294
4.3 Limitations of this study295
There are some limitations associated with the present work. Measurement of resistance296
coefficients was limited to one individual adult airway. From study of a database of 180 scans297
(Nejati et al.38), we believe the airway used have no abnormalities, and to have dimensions298
within the one standard deviation of the population studied. Nevertheless, studies of person-299
to-person variation are needed.300
The upper airway model used lacks the mucosal layer and compliance which the biolog-301
ical upper airway possesses. Though changes in airway surface properties may affect flow302
via development of viscous forces, the thin mucosal layer present in the healthy individual303
is reported to produce little effect on flow.39 Also, a significant upper airway compliance304
may require an extra pressure drop but the small compliance of the upper airway ( ≈ 3305
ml/cmH2O
40) limits this effect. It is plausible however that under conditions of high airway306
compliance and thick mucosal lining, upper airway resistance may differ from those presented307
here.308
The CT on which the model was based was taken in the supine position, but NHF may309
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be administered to patients in a sitting or semi-reclined position. Curvature of the spine310
and thorax affects lung volume and resistance of the chest wall. However, the present study311
focusses on results of the upper airway. Weber et al.41 found that there was no association312
between head posture and resistance to nasal airflow.313
A single healthy breathing pattern has been used, and studies of the effect of breath-314
ing pattern variation from individual to individual, and with disorders such as COPD, are315
needed.316
Furthermore, the evaluation of the resistive component of mechanical work of breathing317
has been restricted to only the upper airway, and the lower airway work has been assumed318
to be the same with or without NHF as mentioned in Section 1.319
5 Conclusions320
In conclusion, an increase in cannula size can increase airway pressure but this may come321
with an increase in expiratory resistance. NHF increases expiratory resistance but reduces322
overall resistive work of breathing through a fall in inspiratory work of breathing, respiratory323
rate and minute volume. An NHF-induced fall in I:E ratio may cause a rise in resistive work324
of breathing.325
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